Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 23255825)

1.

Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.

Besong-Agbo D, Wolf E, Jessen F, Oechsner M, Hametner E, Poewe W, Reindl M, Oertel WH, Noelker C, Bacher M, Dodel R.

Neurology. 2013 Jan 8;80(2):169-75. doi: 10.1212/WNL.0b013e31827b90d1. Epub 2012 Dec 19.

PMID:
23255825
2.

α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease.

Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M.

Int J Mol Sci. 2010 Oct 29;11(11):4257-66. doi: 10.3390/ijms11114257. Review.

3.

Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.

Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE.

Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Epub 2013 Dec 26. Review.

PMID:
24375496
4.

Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.

Neff F, Wei X, Nölker C, Bacher M, Du Y, Dodel R.

Autoimmun Rev. 2008 Jun;7(6):501-7. doi: 10.1016/j.autrev.2008.04.010. Epub 2008 May 1. Review.

PMID:
18558370
5.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
6.

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.

Mollenhauer B, El-Agnaf OM, Marcus K, Trenkwalder C, Schlossmacher MG.

Biomark Med. 2010 Oct;4(5):683-99. doi: 10.2217/bmm.10.90. Review.

PMID:
20945981
7.

Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.

Kim S, Seo JH, Suh YH.

Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S9-13. Review.

PMID:
15109581
8.

Formation and development of Lewy pathology: a critical update.

Jellinger KA.

J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. Review.

PMID:
19711116
9.

Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.

Schmid AW, Fauvet B, Moniatte M, Lashuel HA.

Mol Cell Proteomics. 2013 Dec;12(12):3543-58. doi: 10.1074/mcp.R113.032730. Epub 2013 Aug 21. Review.

10.

Gender differences in Parkinson's disease: focus on plasma α-synuclein.

Caranci G, Piscopo P, Rivabene R, Traficante A, Riozzi B, Castellano AE, Ruggieri S, Vanacore N, Confaloni A.

J Neural Transm. 2013 Aug;120(8):1209-15. doi: 10.1007/s00702-013-0972-6. Epub 2013 Jan 18. Review.

PMID:
23328951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk